The Philadelphia Court of Common Pleas has ruled in favor of Bayer in a Roundup lawsuit. In a press release, Bayer officials ...
In 2022, despite harsh covid-19 lockdowns, 25 new foreign R&D centres opened in Shanghai. Last year, when overall foreign ...
Patients with advanced SSC of the anal canal have a marked survival benefit when immunotherapy is added to standard-of-care ...
After a surprise failure in advanced liver cancer, Merck & Co. and Eisai are hoping new data can make their Keytruda-Lenvima combination a standard of care in intermediate-stage disease. | After a ...
Cellino Biotech, which was founded in 2017, won a federal grant worth up to $25 million to continue to develop its advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback